JP2021519589A5 - - Google Patents

Info

Publication number
JP2021519589A5
JP2021519589A5 JP2020552838A JP2020552838A JP2021519589A5 JP 2021519589 A5 JP2021519589 A5 JP 2021519589A5 JP 2020552838 A JP2020552838 A JP 2020552838A JP 2020552838 A JP2020552838 A JP 2020552838A JP 2021519589 A5 JP2021519589 A5 JP 2021519589A5
Authority
JP
Japan
Prior art keywords
seq
nos
cdr2
sequences shown
cdr3 sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020552838A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519589A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024794 external-priority patent/WO2019191563A1/en
Publication of JP2021519589A publication Critical patent/JP2021519589A/ja
Publication of JP2021519589A5 publication Critical patent/JP2021519589A5/ja
Pending legal-status Critical Current

Links

JP2020552838A 2018-03-29 2019-03-29 インターロイキン１７ａ（ｉｌ−１７ａ）に結合する抗体を用いた自己免疫障害及び炎症障害の治療 Pending JP2021519589A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862649854P 2018-03-29 2018-03-29
US62/649,854 2018-03-29
PCT/US2019/024794 WO2019191563A1 (en) 2018-03-29 2019-03-29 Treatment of autoimmune and inflammatory disorders using antibodies that bind interleukin-17a (il-17a)

Publications (2)

Publication Number Publication Date
JP2021519589A JP2021519589A (ja) 2021-08-12
JP2021519589A5 true JP2021519589A5 (cg-RX-API-DMAC7.html) 2022-03-29

Family

ID=68058546

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020552838A Pending JP2021519589A (ja) 2018-03-29 2019-03-29 インターロイキン１７ａ（ｉｌ−１７ａ）に結合する抗体を用いた自己免疫障害及び炎症障害の治療

Country Status (5)

Country Link
US (1) US20210079087A1 (cg-RX-API-DMAC7.html)
EP (1) EP3773717A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021519589A (cg-RX-API-DMAC7.html)
CN (1) CN112203685A (cg-RX-API-DMAC7.html)
WO (1) WO2019191563A1 (cg-RX-API-DMAC7.html)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE402192T1 (de) * 2000-03-03 2008-08-15 Kyowa Hakko Kogyo Kk Anti-ccr4 antikörper und fragmente davon
AU2003239544A1 (en) * 2002-05-24 2003-12-12 Tularik Inc. Amplification and overexpression of oncogenes
DE10256900A1 (de) * 2002-11-29 2004-06-24 Nemod Immuntherapie Ag Tumorspezifische Erkennungsmoleküle
GB0417487D0 (en) * 2004-08-05 2004-09-08 Novartis Ag Organic compound
US7790862B2 (en) * 2006-06-13 2010-09-07 Zymogenetics, Inc. IL-17 and IL-23 antagonists and methods of using the same
TW200815469A (en) * 2006-06-23 2008-04-01 Astrazeneca Ab Compounds
EP2046835B1 (en) * 2006-08-11 2011-10-26 Schering Corporation Antibodies to il-17a
EP2493506B1 (en) * 2009-10-30 2019-04-10 Janssen Biotech, Inc. Il-17a antagonists
LT2953969T (lt) * 2013-02-08 2019-12-10 Novartis Ag Anti-il-17a antikūnai ir jų panaudojimas autoimuninių ir uždegiminių ligų gydymui
EP2970446A1 (en) * 2013-03-15 2016-01-20 Amgen Research (Munich) GmbH Antibody constructs for influenza m2 and cd3

Similar Documents

Publication Publication Date Title
JP2020508655A5 (cg-RX-API-DMAC7.html)
JP2025016349A5 (cg-RX-API-DMAC7.html)
JP2018522888A5 (cg-RX-API-DMAC7.html)
RU2019121086A (ru) Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1)
JP2017504578A5 (cg-RX-API-DMAC7.html)
JP2018506964A5 (cg-RX-API-DMAC7.html)
JP2020514277A5 (cg-RX-API-DMAC7.html)
JP2019532619A5 (cg-RX-API-DMAC7.html)
JP2023551027A5 (cg-RX-API-DMAC7.html)
IL259747B (en) Antibodies against fcrl5 and methods of their use
RU2010149746A (ru) Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
JP2012525829A5 (cg-RX-API-DMAC7.html)
JP2010538608A5 (cg-RX-API-DMAC7.html)
FI3322727T3 (fi) Humanisoituja tai kimeerisiä CD3-vasta-aineita
JP2018526981A5 (cg-RX-API-DMAC7.html)
JP2022545647A5 (cg-RX-API-DMAC7.html)
JP2013545738A5 (cg-RX-API-DMAC7.html)
JP2020519308A5 (cg-RX-API-DMAC7.html)
US20230114801A1 (en) MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF
RU2018102803A (ru) Мультивалентные и мультиспецифические гибридные белки, связывающиеся с dr5
JP2022549172A5 (cg-RX-API-DMAC7.html)
JP2020513759A5 (cg-RX-API-DMAC7.html)
JP2023520969A5 (cg-RX-API-DMAC7.html)
JP2024516595A5 (cg-RX-API-DMAC7.html)
JP2012530487A5 (cg-RX-API-DMAC7.html)